Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PV0Q | ISIN: CA87975M2085 | Ticker-Symbol: 3D0A
Tradegate
27.03.24
18:27 Uhr
0,084 Euro
+0,005
+6,37 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
TELO GENOMICS CORP Chart 1 Jahr
5-Tage-Chart
TELO GENOMICS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0700,07819:55
0,0700,07718:34

Aktuelle News zur TELO GENOMICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.02.Telo Genomics kick-starts clinical trial for multiple myeloma patients2
13.02.Telo Genomics Corp (2): Telo Genomics begins MRD clinical trial for MM patients2
13.02.Telo Genomics Corp.: Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients297Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has received the first patient sample...
► Artikel lesen
30.01.Telo Genomics Corp (2): Telo Genomics hires Trusted Health Advisors2
30.01.Telo Genomics Corp.: Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US438Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has engaged Trusted Health Advisors...
► Artikel lesen
08.12.23Telo Genomics Corp (2): Telo Genomics CEO Weinberg resigns11
06.12.23Telo Genomics Corp.: Telo Genomics Gears up for American Society of Hematology Conference544Toronto, Ontario--(Newsfile Corp. - December 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), an emerging molecular testing platform provider leveraging...
► Artikel lesen
16.11.23Telo Genomics Corp (2): Telo Genomics begins physician experience program7
16.11.23Telo Genomics launches physician-based cancer program in U.S.3
16.11.23Telo Genomics Corp.: Telo Genomics Launches Physician Experience Program in the United States511SMART Observational Study a Critical Step Toward Full Platform Availability Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the...
► Artikel lesen
07.11.23Telo Genomics Corp (2): Telo proceeds to CAP accreditation assessment audit2
07.11.23Telo Genomics Corp.: Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists380An Important Accreditation Milestone Achieved Towards Full Commercial Availability Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A)...
► Artikel lesen
01.11.23Telo Genomics Corp (2): Telo to present on TeloView-SMM at ASH meeting1
01.11.23Telo Genomics Corp.: American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting276ASH is the world leader in supporting clinical and scientific hematology research Toronto, Ontario--(Newsfile Corp. - November 1, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company"...
► Artikel lesen
26.10.23Telo Genomics Corp (2): Telo Genomics receives ISO accreditation2
26.10.23Telo Genomics Corp.: Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation304Authorizes Telo to Offer its Laboratory Developed Tests ("LDT") from its Central Lab Toronto, Ontario--(Newsfile Corp. - October 26, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company"...
► Artikel lesen
17.10.23Telo Genomics launches cancer diagnostic platform in the U.S.2
17.10.23Telo Genomics Corp (2): Telo rolls out TeloViewSMM for U.S. clinicians1
17.10.23Telo Genomics Corp.: Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM - An Important Commercial Milestone Achieved284TeloView Analyses Telomeres to Accurately Predict and Characterize Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - October 17, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company"...
► Artikel lesen
12.10.23Telo Genomics Corp.: Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting360Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce that it has participated in the International...
► Artikel lesen
Seite:  Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1